Effect of Environmental Substances on the Activity of Arylamine N-Acetyltransferases
Journal:
Current Drug Metabolism
Volume:
9
Page:
505-509
Author(s):
Fernando Rodrigues-Lima, Julien Dairou and Jean-Marie Dupret
Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Journal:
Current Drug Metabolism
Volume:
9
Page:
520-531
Author(s):
Jose A.G Agundez
Using Bioinformatics Techniques for Gene Identification in Drug Discovery and Development
Journal:
Current Drug Metabolism
Volume:
9
Page:
567-573
Author(s):
Yi-Ping Phoebe Chen and Feng Chen
The Epidemiology of Sepsis
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1833-1839
Author(s):
Katherine E. Hodgin and Marc Moss
Non-Pharmacologic Strategies in Hematopoietic Stem Cell Transplantation
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1987-1996
Author(s):
Jennifer Schneiderman
Neutrophil Elastase Inhibition: A New Cancer Therapy
Journal:
Current Enzyme Inhibition
Volume:
4
Page:
82-85
Author(s):
Takashi Sato, Miwa Yoshida, Satoshi Takahashi, Takashi Fukutomi and Jun-Ichi Yamashita
Potential Therapeutic Applications of miRNA-Based Technology in Hematological Malignancies
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2040-2050
Author(s):
Elisa Barbarotto and George A. Calin
Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2051-2060
Author(s):
M. P. Bernard, S. Bancos, P. J. Sime and R. P. Phipps
Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2061-2074
Author(s):
Wim J. van Blitterswijk and Marcel Verheij
Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2075-2084
Author(s):
Carlo Mischiati, Elisabetta Melloni, Federica Corallini, Daniela Milani, Carlo Bergamini and Mauro Vaccarezza